Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
The participant is male or female, 30 to 80 years of age on the date of informed... [+7]
The participant has a history of type 1 diabetes mellitus. [+16]